Literature DB >> 29669261

ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome.

Ah-Reum Oh1, Seonyong Sohn1, Junghoon Lee1, Jong-Min Park2, Ki Taek Nam3, Ki-Baik Hahm2, Young-Bum Kim4, Ho-Jae Lee1, Ji-Young Cha5.   

Abstract

OBJECTIVE: Fructose malabsorption is a common digestive disorder in which absorption of fructose in the small intestine is impaired. An abnormality of the main intestinal fructose transporter proteins has been proposed as a cause for fructose malabsorption. However the underlying molecular mechanism for this remains unclear. In this study, we investigated whether carbohydrate response element-binding protein (ChREBP) plays a role in intestinal fructose absorption through the regulation of genes involved in fructose transport and metabolism and ion transport.
METHODS: Wild type (WT) and Chrebp knockout (KO) mice (6 or 8 weeks old) were fed a control diet (55% starch, 15% maltodextrin 10) or high-fructose diet (HFrD, 60% fructose, 10% starch) for 3-12 days. Body weight and food intake were measured, signs of fructose malabsorption were monitored, and the expression of genes involved in fructose transport/metabolism and ion transport was evaluated. Furthermore, transient transfection and chromatin immunoprecipitation were performed to show the direct interaction between ChREBP and carbohydrate response elements in the promoter of Slc2A5, which encodes the fructose transporter GLUT5.
RESULTS: Chrebp KO mice fed the control diet maintained a constant body weight, whereas those fed a HFrD showed significant weight loss within 3-5 days. In addition, Chrebp KO mice fed the HFrD exhibited a markedly distended cecum and proximal colon containing both fluid and gas, suggesting incomplete fructose absorption. Fructose-induced increases of genes involved in fructose transport (GLUT5), fructose metabolism (fructokinase, aldolase B, triokinase, and lactate dehydrogenase), and gluconeogenesis (glucose-6-phosphatase and fructose-1,6-bisphosphatase) were observed in the intestine of WT but not of Chrebp KO mice. Moreover the Na+/H+ exchanger NHE3, which is involved in Na+ and water absorption in the intestine, was significantly decreased in HFrD-fed Chrebp KO mice. Consistent with this finding, the high-fructose diet-fed Chrebp KO mice developed severe diarrhea. Results of chromatin immunoprecipitation assays showed a direct interaction of ChREBP with the Glut5 promoter, but not the Nhe3 promoter, in the small intestine. Ectopic co-expression of ChREBP and its heterodimer partner Max-like protein X activated the Glut5 promoter in Caco-2BBE cells.
CONCLUSIONS: ChREBP plays a key role in the dietary fructose transport as well as conversion into lactate and glucose through direct transcriptional control of genes involved in fructose transport, fructolysis, and gluconeogenesis. Moreover, ablation of Chrebp results in a severe diarrhea in mice fed a high-fructose diet, which is associated with the insufficient induction of GLUT5 in the intestine.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ChREBP; Diarrhea; Fructose absorption; GLUT5; Intestine

Mesh:

Substances:

Year:  2018        PMID: 29669261     DOI: 10.1016/j.metabol.2018.04.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

Review 1.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

2.  Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction.

Authors:  Ana Andres-Hernando; David J Orlicky; Masanari Kuwabara; Takuji Ishimoto; Takahiko Nakagawa; Richard J Johnson; Miguel A Lanaspa
Journal:  Cell Metab       Date:  2020-06-04       Impact factor: 27.287

Review 3.  Molecular aspects of fructose metabolism and metabolic disease.

Authors:  Mark A Herman; Morris J Birnbaum
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

Review 4.  Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets.

Authors:  Liora S Katz; Sharon Baumel-Alterzon; Donald K Scott; Mark A Herman
Journal:  J Biol Chem       Date:  2021-04-02       Impact factor: 5.157

Review 5.  Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.

Authors:  Ho-Jae Lee; Ji-Young Cha
Journal:  BMB Rep       Date:  2018-09       Impact factor: 4.778

6.  Species-Specific Glucose-6-Phosphatase Activity in the Small Intestine-Studies in Three Different Mammalian Models.

Authors:  Viola Varga; Zsófia Murányi; Anita Kurucz; Paola Marcolongo; Angelo Benedetti; Gábor Bánhegyi; Éva Margittai
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

7.  Fructose Consumption by Adult Rats Exposed to Dexamethasone In Utero Changes the Phenotype of Intestinal Epithelial Cells and Exacerbates Intestinal Gluconeogenesis.

Authors:  Gizela A Pereira; Frhancielly S Sodré; Gilson M Murata; Andressa G Amaral; Tanyara B Payolla; Carolina V Campos; Fabio T Sato; Gabriel F Anhê; Silvana Bordin
Journal:  Nutrients       Date:  2020-10-07       Impact factor: 5.717

8.  Gryllus bimaculatus extract protects against lipopolysaccharide and palmitate-induced production of proinflammatory cytokines and inflammasome formation.

Authors:  Woo-Jae Park; Jung-Soon Han
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

Review 9.  Intestinal Fructose and Glucose Metabolism in Health and Disease.

Authors:  Beatriz Merino; Cristina M Fernández-Díaz; Irene Cózar-Castellano; German Perdomo
Journal:  Nutrients       Date:  2019-12-29       Impact factor: 5.717

10.  Thioredoxin Interacting Protein Is Required for a Chronic Energy-Rich Diet to Promote Intestinal Fructose Absorption.

Authors:  Anu Shah; Sezin Dagdeviren; Jordan P Lewandowski; Angela B Schmider; Elisabeth M Ricci-Blair; Niranjana Natarajan; Henna Hundal; Hye Lim Noh; Randall H Friedline; Charles Vidoudez; Jason K Kim; Amy J Wagers; Roy J Soberman; Richard T Lee
Journal:  iScience       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.